Adenosine: a prototherapeutic concept in neurodegeneration.
D000241:Adenosine / Q000494:pharmacology* / Q000502:physiology* / Q000627:therapeutic use; D000818:Animals; D001921:Brain / Q000187:drug effects / Q000378:metabolism*; D001927:Brain Diseases / Q000378:metabolism / Q000503:physiopathology*; D018698:Glutamic Acid / Q000378:metabolism; D006801:Humans; D009410:Nerve Degeneration / Q000187:drug effects / Q000502:physiology*; D018696:Neuroprotective Agents / Q000494:pharmacology* / Q000627:therapeutic use; D018047:Receptors, Purinergic P1 / Q000378:metabolism; D013312:Stress, Physiological / Q000378:metabolism*
D018696:Neuroprotective Agents; D018047:Receptors, Purinergic P1; D018698:Glutamic Acid; D000241:Adenosine